Donor-specific HLA antibodies: Risk factors and outcomes after kidney transplantation

Transplantation Proceedings

Volumn 43, Issue 6, 2011, Pages 2154-2156

  Berga, J Kanter ^a   Mateu, L M Pallardo ^a   Catalan, S Beltran ^a   Alcaraz, N Puig ^a   Calabuig, A Sancho ^a   Martinez, E Gavela ^a   Bernabeu, A Avila ^a   Albiach, J Crespo ^a  

^a HOSPITAL UNIVERSITARIO DR PESET   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

BASILIXIMAB; CYCLOSPORIN A; HLA ANTIBODY; TACROLIMUS; THYMOCYTE ANTIBODY;

ACUTE GRAFT REJECTION; ADULT; ARTICLE; CADAVER DONOR; CADAVER KIDNEY; COLD ISCHEMIA; CROSS-SECTIONAL STUDY; DELAYED GRAFT FUNCTION; FEMALE; FOLLOW UP; GRAFT RECIPIENT; GRAFT SURVIVAL; HUMAN; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RISK FACTOR; TREATMENT OUTCOME;

ADULT; CHI-SQUARE DISTRIBUTION; CROSS-SECTIONAL STUDIES; FEMALE; GRAFT REJECTION; GRAFT SURVIVAL; HISTOCOMPATIBILITY; HISTOCOMPATIBILITY TESTING; HLA ANTIGENS; HUMANS; ISOANTIBODIES; KAPLAN-MEIER ESTIMATE; KIDNEY TRANSPLANTATION; LOGISTIC MODELS; MALE; MIDDLE AGED; RISK ASSESSMENT; RISK FACTORS; SPAIN; TIME FACTORS; TREATMENT OUTCOME;

EID: 80051697372     PISSN: 00411345     EISSN: 18732623     Source Type: Journal    
DOI: 10.1016/j.transproceed.2011.06.053     Document Type: Article

References (14)

1. H.U. Meier-Kriesche, J.D. Schold, and T.R. Srinivas Lack of improvement in renal allograft survival despite a marked decrease in acute rejection rates over the most recent era Am J Transplant 4 2004 378
2. C. Susal, B. Dohler, and G. Opelz Presensitized kidney graft recipients with HLA class I and II antibodies are at increased risk for graft failure: a Collaborative Transplant Study report Hum Immunol 70 2009 569
3. N. Lachmann, P.I. Terasaki, and K. Budde Antihuman leukocyte antigen and donor-specific antibodies detected by Luminex posttransplant serve as biomarkers for chronic rejection of renal allografts Transplantation 87 2009 1505
4. P. Kimball, M. Baker, M. Wagner, and A. King Surveillance of alloantibodies after transplantation identifies the risk of chronic rejection Kidney Int 79 2011 1131
5. P.I. Terasaki, and M. Ozawa Predicting kidney graft failure by HLA antibodies: a prospective trial Am J Transplant 4 2004 438
6. P.I. Terasaki, and J. Cai Human leukocyte antigen antibodies and chronic rejection: from association to causation Transplantation 86 2008 377
7. J.C. Scornik, G. Guerra, and J.D. Schold Value of posttransplant antibody tests in the evaluation of patients with renal graft dysfunction Am J Transplant 7 2007 1808
8. P.C. Lee, L. ZHU, and P.I. Terasaki HLA-specific antibodies developed in the first year postransplant are predictive of chronic rejection and renal graft loss Transplantation 88 2009 568
9. K. Mizutani, P. Terasaki, and A. Rosen Serial ten-year follow-up of HLA and MICA antibody production prior to kidney graft failure Am J Transplant 5 2005 2265
10. C. Ssal, J. Ovens, and K. Mahmoud No association of kidney graft loss with human leukocyte antigen antibodies detected exclusively by sensitive Luminex single-antigen testing: a Collaborative Transplant Study report Transplantation 91 2011 883
11. Q. Zhang, L.W. Liang, and D.W. Gjertson Development of postransplant antidonor HLA antibodies is associated with acute humoral rejection and early graft dysfunction Transplantation 79 2005 591
12. J.S. Gill, D. Landsberg, and O. Johnston Screening for de novo antihuman leukocyte antigen antibodies in nonsensitized kidney transplant recipients does not predict acute rejection Transplantation 89 2010 178
13. A. Piazza, E. Poggi, and L. Borrelli Impact of donor specific antibodies in chronic rejection occurrence and graft loss in renal transplantation: Postransplant analysis using flow cytometry techniques Transplantation 71 2001 1106
14. M.J. Everly, and P.I. Terasaki Monitoring and treating postransplant human leukocyte antigen antibodies Hum Immunol 70 2009 655